Unknown

Dataset Information

0

The UK SPIRIT 1 trial in newly diagnosed chronic myeloid leukaemia.

ABSTRACT:

SUBMITTER: Gallipoli P 

PROVIDER: S-EPMC7613110 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The UK SPIRIT 1 trial in newly diagnosed chronic myeloid leukaemia.

Gallipoli Paolo P   Clark Richard E RE   Byrne Jenny J   Apperley Jane F JF   Milojkovic Dragana D   Foroni Letizia L   Goldman John M JM   O'Brien Stephen S  

British journal of haematology 20220106 6

Similar Datasets

Unknown Nilotinib dose-optimization in newly diagnosed chronic myeloid leukaemia in chronic phase: final results from ENESTxtnd.
| S-EPMC5655928 | biostudies-literature
Unknown Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial.
| S-EPMC4274978 | biostudies-literature
Unknown Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factors.
| S-EPMC8563490 | biostudies-literature
Unknown Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial.
| S-EPMC4979199 | biostudies-literature
Unknown Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial.
| S-EPMC9252917 | biostudies-literature
Unknown Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
| S-EPMC5966023 | biostudies-literature
Unknown Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial.
| S-EPMC8410595 | biostudies-literature
Unknown Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE).
| S-EPMC7187446 | biostudies-literature
Unknown Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006).
| S-EPMC4365700 | biostudies-literature
Unknown Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia.
| S-EPMC4305212 | biostudies-literature